These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9632453)

  • 61. Cerebral Venous Thrombosis.
    Biousse V; Tong F; Newman NJ
    Curr Treat Options Neurol; 2003 Sep; 5(5):409-420. PubMed ID: 12895403
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cerebral Venous Thrombosis.
    Biousse V; Tong F; Newman NJ
    Curr Treat Options Cardiovasc Med; 2003 Jul; 5(3):181-192. PubMed ID: 12777196
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic thrombophilia in patients with retinal vascular occlusion.
    Greiner K; Peetz D; Winkgen A; Prellwitz W; Pfeiffer N; Hafner G
    Int Ophthalmol; 1999; 23(3):155-60. PubMed ID: 11456253
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease.
    Chak M; Wallace GR; Graham EM; Stanford MR
    Br J Ophthalmol; 2001 Jul; 85(7):883-6. PubMed ID: 11423467
    [No Abstract]   [Full Text] [Related]  

  • 65. The impact of molecular medicine upon early cardiovascular drug development.
    Lunnon MW; Braddock M
    Br J Clin Pharmacol; 2000 Jul; 50(1):1-8. PubMed ID: 10886110
    [No Abstract]   [Full Text] [Related]  

  • 66. Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability.
    Vandenbroucke JP
    BMJ; 1998 Aug; 317(7157):483-4. PubMed ID: 9712588
    [No Abstract]   [Full Text] [Related]  

  • 67. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives.
    Bridey F; Wolff M; Laissy JP; Morin V; Lefebvre M; de Prost D
    Thromb Haemost; 1995 Nov; 74(5):1382. PubMed ID: 8607129
    [No Abstract]   [Full Text] [Related]  

  • 69. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Advances in the etiology and treatment of venous thromboembolism.
    Comp PC
    Adv Intern Med; 1999; 44():59-89. PubMed ID: 9929705
    [No Abstract]   [Full Text] [Related]  

  • 71. Venous thrombosis--the interaction of genes and environment.
    Bertina RM; Rosendaal FR
    N Engl J Med; 1998 Jun; 338(25):1840-1. PubMed ID: 9632453
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.